Please assess the completion status of the following clinical trial:

Trial Title: Usefulness of Extracorporeal Removal of sFLT-1 in Women With Very Early Severe Preeclampsia

Study Design Characteristics:
- Allocation: None
- Intervention Model: SINGLE_GROUP
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 1.0

Eligibility Criteria:
Inclusion Criteria:~* Severe preeclampsia at less than 26 weeks' gestation~* Singleton pregnancy~* Signed consent~Exclusion Criteria:~* Multiple pregnancy~* Gestational age at 26 or above weeks' gestation~* Estimated foetal weight at diagnosis \<5th percentile~* Abnormal fetal heart rate at entry, where feasible (\>24 weeks' gestation)~* Maternal complications at diagnosis: Uncontrolled blood pressure, HELLP syndrome, abruption, eclampsia pulmonary edema, renal failure, liver hematoma

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 45 Years
- Healthy Volunteers: f

Study Arms:
- Apheresis arm (Type: EXPERIMENTAL): Apheresis for extracorporal removal of sFlt-1

Based on this trial design, predict the completion outcome and termination type (if applicable).